Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain

Health Policy

Volumn 95, Issue 2-3, 2010, Pages 245-254

  Lluch, Maria ^a   Kanavos Panos, P ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Access; Community Pharmacy; Efficiency; Equity; EU health policy; Incentives; Liberalisation; Pharmacy (de)regulation; Reimbursement; Spain; UK

Indexed keywords

ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG LEGISLATION; DRUG QUALITY; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LICENSING; ORGANIZATIONAL EFFICIENCY; PATIENT CARE; PHARMACY; REGISTRATION; REIMBURSEMENT; SEMI STRUCTURED INTERVIEW; SPAIN; UNITED KINGDOM;

COMMERCE; EFFICIENCY, ORGANIZATIONAL; GOVERNMENT REGULATION; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; LICENSURE, PHARMACY; MARKETING OF HEALTH SERVICES; MODELS, ORGANIZATIONAL; MOTIVATION; NATIONAL HEALTH PROGRAMS; NONPRESCRIPTION DRUGS; OWNERSHIP; PHARMACIES; QUESTIONNAIRES; SPAIN; STATE MEDICINE;

EID: 77950946446     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.11.002     Document Type: Article

References (38)

1. OECD. Regulatory reform in Ireland: the role of competition policy in regulatory reform; 2001.
2. Volkerink B., Bas Pd, Gorp Nv, Philipsen N. Study of regulatory restrictions in the field of pharmacies. ECORYS Nederland BV in cooperation with METRO - University of Maastricht 2007, European Commission, Internal Market and Services DG, Rotterdam.
3. OFT The control of entry regulations and retail pharmacy services in the UK 2003, OFT - Office of Fair Trading, UK.
4. CGOF Argumentario modelo español de farmacia 2006, Consejo General de Colegios Oficiales de Farmacéuticos, Madrid.
5. CGOF Los Modelos de Farmacia en la Unión Europea 2007, Consejo General de Colegios Oficiales de Farmacéuticos, Madrid.
6. PGEU-Secretariat PGEU Contribution to the Internal Market consultation 2006, PGEU - Pharmaceutical Group of the European Union, Brussels.
7. Almarsdóttir A.B., Morgall J.M., Bjornsdottir I. A question of emphasis: efficiency or equality in the provision of pharmaceuticals. International Journal of Health Planning and Management 2000, 15:149-161.
8. Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy 2005, 75:9-17.
9. Morgall J.M., Almarsdottir A.B. No struggle, no strength: how pharmacists lost their monopoly. Social Science & Medicine 1999, 48:1247-1258.
10. Larsen J.B., Vrangbæk K., Traulsen J.M. Advocacy coalitions and pharmacy policy in Denmark - solid cores with fuzzy edges. Social Science & Medicine 2006, 63:212-224.
11. ECJ. Joined Cases C 171/07 and C 172/07: OJ; 2007. p. 11.
12. ECJ. Case C 393/08: OJ; 2008. p. 28.
13. WHO. The World health report 2000 " Health systems: improving performance" Geneva: World Health Organization; 2000.
14. PGEU-Secretariat Consultation regarding the discussion document for a health strategy " Health in Europe: a strategic approach" 2007, PGEU - Pharmaceutical Group of the European Union, Brussels.
15. Almarsdóttir A.B., Traulsen J.M. Studying and evaluating pharmaceutical policy - becoming a part of the policy and consultative process. Pharmacy World & Science 2006, 28:6-12.
16. Vogler S., Arts D., Habl C. Community Pharmacy in Europe: Lessons from deregulation - case studies 2006, ÖBIG (Austrian Health Institute) commissioned by PGEU (Pharmaceutical Group of the European Union), Vienna.
17. Mossialos E., Mrazek M. The regulation of pharmacies in six countries (annex III) 2003, OFT - Office of Fair Trading, London.
18. EL-Global La oficina de Farmacia en el Sistema Nacional de Salud: informe por comunidades (Special section) 2008, EL-Global, Madrid.
19. Ley General de Sanidad de 1986: Madrid; 1986.
20. Ley de Regulacion de Servicio de las oficinas de Farmacia 1997. Madrid; 1997.
21. Baleares. Ley 7/1998, de 12 de Noviembre, de ordenación farmacééutica de las Islas Baleares. BOE: BOE; 1998.
22. Canarias. Ley 4/2005, de 13 de Julio, de ordenacion farmaceutica de Canarias: BOE; 2005.
23. Navarra. Ley Foral 12/2000, de 16 de Noviembre, de atencion farmaceutica. BOE; 2000; 20/2/2001.
24. Andalucia. Ley 22/2007, de 18 de Diciembre, de farmacia de Andalucia: BOE; 2007.
25. ECJ. Case C 570/07: OJ; 2008. p. 13.
26. ECJ. Case C 563/08: OJ; 2009. p. 21.
27. EC. Article 43 EC Treaty Official Journal C 325, 24/12/2002. p. 0052; Official Journal C 340, 10/11/1997. p. 0195 - Consolidated version; Official Journal C 224, 31/08/1992. p. 0021 - Consolidated version: OJ; 2002.
28. Portalfarma La farmacia en España 2008, Consejo General de Colegios Oficiales de Farmaceuticos, Madrid.
29. General Pharmaceutical services in England and wales 1997-98 to 2006-07: NHS Information Centre; 2008.
30. DoH. Public Health Statistics: Department of Health; 2008.
31. DoH. The NHS (Pharmaceutical Services) Regulations 2005: Information for Primary Care Trusts: DoH - Department of Health; 2007.
32. PSNC. The new NHS Community Pharmacy service - a summary of the structure. PSNC - Pharmaceutical Services Negotiating Committee; 2004.
33. Blenkinsopp A., Bond C., Celino G., Inch J., Gray N. National evaluation of the new Community Pharmacy contract. The Pharmacy Practice Research Trust 2007.
34. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality 2004, Open University Press, Berkshire.
35. Galbraith A. Review of NHS pharmaceutical contractual arrangements 2007, Department of Health (UK), London.
36. Le Grand J. Motivation, agency, and public policy of knights and knaves, pawns and queens 2003, Oxford University Press, Oxford.
37. PGEU-Secretariat Patient Safety: maximizing Patient Safety in Europe through the safe use of medicines 2007, PGEU - Pharmaceutical Group of the European Union, Brussels.
38. Aspden P., Corrigan J., Wolcott J., Erickson S. Patient safety: achieving a new standard for care 2004, National Academies Press, Washington.